EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 -1.329
March 31, 2026 -1.396
December 31, 2025 -1.394
September 30, 2025 -1.458
June 30, 2025 -1.323
March 31, 2025 -1.209
December 31, 2024 -1.206
September 30, 2024 -1.007
June 30, 2024 -1.190
March 31, 2024 -1.030
September 30, 2023 -0.9283
June 30, 2023 -0.654
March 31, 2023 -0.3703
June 30, 2022 -0.5122
March 31, 2022 -0.4408
December 31, 2021 -0.4068
September 30, 2021 -0.3983
June 30, 2021 -0.3441
March 31, 2021 -0.4442
December 31, 2020 -0.4645
September 30, 2020 -0.4934
June 30, 2020 -0.511
March 31, 2020 -0.499
December 31, 2019 -0.5857
September 30, 2019 -0.6626
Date Value
June 30, 2019 -0.7695
March 31, 2019 -1.006
December 31, 2018 -1.039
September 30, 2018 -1.128
June 30, 2018 -1.20
March 31, 2018 -1.10
December 31, 2017 -1.10
September 30, 2017 -1.10
June 30, 2017 -1.10
March 31, 2017 -1.00
December 31, 2016 -1.00
September 30, 2016 -0.90
June 30, 2016 -0.80
March 31, 2016 -0.80
December 31, 2015 -0.80
September 30, 2015 -0.80
June 30, 2015 -0.70
March 31, 2015 -0.8072
December 31, 2014 -1.107
September 30, 2014 -1.107
June 30, 2014 -1.607
March 31, 2014 -1.589
December 31, 2013 -1.289
September 30, 2013 -1.389
June 30, 2013 -1.089

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Anika Therapeutics, Inc. -0.2741
MiMedx Group, Inc. 0.0395
ABVC BioPharma, Inc. -0.2878
Enovis Corp. -19.24
Edwards Lifesciences Corp. 1.685